- €1.89bn
- €2.83bn
- €1.16bn
Europe Research Roundup: Airbus, Capgemini, Euronext
Brief: Dermapharm Expects Consolidated Revenue Of Between Eur 1.1 Bln And Eur 1.2 Bln In 2025
Europe Research Roundup: ASML Holding, HSBC, NKT A/S
Brief: Dermapharm Holding Confirms FY Outlook
Brief: Dermapharm 9M Adjusted EBITDA EUR 240.3 Million
Brief: Dermapharm Holding SE - Confirms Outlook
Europe Research Roundup: Draegerwerk, Hikma, Novartis
Brief: Dermapharm Holding SE - Outlook For 2024 Confirmed
Brief: Dermapharm Holding Confirms Outlook For 2024
Brief: Dermapharm H1 Adjusted EBITDA EUR 153 Million
Brief: Dermapharm Holding Confirms 2024 Outlook
Brief: Dermapharm Q1 Adjusted EBITDA EUR 88.7 Million
Brief: Dermapharm Confirms Guidance
Brief: Dermapharm Holding Sees 2024 Adjusted Consolidated EBITDA Between EUR 305 And Eur 315 Mln
Brief: Dermapharm FY Adjusted EBITDA EUR 310.2 Million
Dermapharm up after 9-month results beat forecasts
Brief: Dermapharm Holding Q3 Unadjusted EBITDA At EUR 208.4 Mln
Brief: Dermapharm 9M Adjusted EBITDA EUR 243.8 Million
Brief: Dermapharm Confirms Outlook For 2023 Overall